|
Name |
17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile
|
| Molecular Formula | C20H27NO2 | |
| IUPAC Name* |
17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile
|
|
| SMILES |
CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C#N)O)C
|
|
| InChI |
InChI=1S/C20H27NO2/c1-18-8-5-14(22)11-13(18)3-4-15-16(18)6-9-19(2)17(15)7-10-20(19,23)12-21/h11,15-17,23H,3-10H2,1-2H3
|
|
| InChIKey |
JYCSLUASXDFIEL-UHFFFAOYSA-N
|
|
| Synonyms |
17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile; Preg-4-en-3-one, 17alpha-hydroxy-17beta-cyano-; 17-Hydroxy-3-oxoandrost-4-ene-17-carbonitrile; Preg-4-en-3-one, 17.alpha.-hydroxy-17.beta.-cyano-; BBL033644; STL372842; AKOS025247966; VS-12199; 17-Hydroxy-3-oxoandrost-4-ene-17-carbonitrile #; 1-hydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1-carbonitrile
|
|
| CAS | NA | |
| PubChem CID | 534560 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 313.4 | ALogp: | 3.2 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 61.1 | Aromatic Rings: | 4 |
| Heavy Atoms: | 23 | QED Weighted: | 0.672 |
| Caco-2 Permeability: | -4.856 | MDCK Permeability: | 0.00002860 |
| Pgp-inhibitor: | 0.889 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.002 |
| 30% Bioavailability (F30%): | 0.006 |
| Blood-Brain-Barrier Penetration (BBB): | 0.922 | Plasma Protein Binding (PPB): | 93.39% |
| Volume Distribution (VD): | 0.717 | Fu: | 5.41% |
| CYP1A2-inhibitor: | 0.063 | CYP1A2-substrate: | 0.931 |
| CYP2C19-inhibitor: | 0.451 | CYP2C19-substrate: | 0.862 |
| CYP2C9-inhibitor: | 0.254 | CYP2C9-substrate: | 0.296 |
| CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.178 |
| CYP3A4-inhibitor: | 0.237 | CYP3A4-substrate: | 0.918 |
| Clearance (CL): | 5.667 | Half-life (T1/2): | 0.326 |
| hERG Blockers: | 0.066 | Human Hepatotoxicity (H-HT): | 0.594 |
| Drug-inuced Liver Injury (DILI): | 0.188 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.423 | Maximum Recommended Daily Dose: | 0.921 |
| Skin Sensitization: | 0.097 | Carcinogencity: | 0.899 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
| Respiratory Toxicity: | 0.972 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005239 | ![]() |
0.470 | D0Z1XD | ![]() |
0.786 | ||
| ENC002882 | ![]() |
0.470 | D06XMU | ![]() |
0.640 | ||
| ENC003458 | ![]() |
0.470 | D08TEJ | ![]() |
0.600 | ||
| ENC001764 | ![]() |
0.470 | D07BSQ | ![]() |
0.580 | ||
| ENC002305 | ![]() |
0.407 | D09IPV | ![]() |
0.552 | ||
| ENC001029 | ![]() |
0.354 | D00AEQ | ![]() |
0.546 | ||
| ENC005141 | ![]() |
0.352 | D0G8BV | ![]() |
0.542 | ||
| ENC005144 | ![]() |
0.340 | D0GL7U | ![]() |
0.518 | ||
| ENC004615 | ![]() |
0.330 | D0I2SD | ![]() |
0.517 | ||
| ENC005068 | ![]() |
0.324 | D0KR5B | ![]() |
0.517 | ||